Calendar Spyre Therapeutics, Inc.

Equities

SYRE

US00773J2024

Delayed Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
37.93 USD +2.51% Intraday chart for Spyre Therapeutics, Inc. -4.84% +76.25%

Chart calendar Spyre Therapeutics, Inc.

a4262dd62e0792c62.cNNJy_aj9arVvbk3aZrOJhROpvuN0AH7tHUbBLOnnFE.Hpcm86nVoeWP5MF7IKKobUch94rIo3O4zU1zRtDJq2YbpHqlv8Kt8Ibu4A~cac35fc47da3c3d3056b0c8b8ce626ea

Upcoming events on Spyre Therapeutics, Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-02-26 Q4 2024 Earnings Release (Projected)

Past events on Spyre Therapeutics, Inc.

2024-03-05 02:10 pm TD Cowen Health Care Conference
2024-02-29 04:05 pm Q4 2023 Earnings Release
2024-02-22 ECCO Congress - SPY002
2024-02-22 ECCO Congress - SPY001
2024-02-22 ECCO Congress - Novel Extended Half-Life Monoclonal Antibody Drug
2023-11-20 Special Meeting
2023-11-20 Extraordinary Shareholders Meeting
2023-11-16 08:00 am Jefferies London Healthcare Conference
2023-11-14 03:35 pm Stifel Healthcare Conference
2023-11-09 04:05 pm Q3 2023 Earnings Release
2023-11-07 09:10 am Guggenheim Securities Inflammation & Immunology Conference
2023-09-20 11:00 am Stifel Immunology & Inflammation Virtual Summit
2023-08-11 07:00 am Q2 2023 Earnings Release
2023-06-22 09:00 am Acquisition of Spyre Therapeutics Inc by Aeglea BioTherapeutics, Inc Call
2023-06-06 10:00 am Annual General Meeting
2023-05-11 07:01 am Q1 2023 Earnings Release
2023-03-16 10:45 am ACMG Clinical Genetics Meeting
2023-03-02 07:01 am Q4 2022 Earnings Release
2023-01-08 JP Morgan Healthcare Conference
2022-11-28 Piper Sandler Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,30
-
0,00
0,00
-
18,7
17,4
7.72%
2,33
2,23
4.35%
0,89
1,08
-18.22%

6,82

EBITDA
Million USD
Released
Forecast
Spread
-79,9
-83,0
3.72%
-80,5
-89,0
9.57%
0,00
0,00
-
0,00
0,00
-
-242
-224
-8.03%

-132

EBIT
Million USD
Released
Forecast
Spread
-80,3
-80,8
0.62%
-81,5
-80,6
-1.05%
-65,6
-66,0
0.55%
-84,8
-83,9
-1.05%
-242
-224
-8.21%

-157

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-78,3
-78,8
0.66%
-80,9
-81,1
0.23%
-65,7
-66,1
0.7%
-84,0
-84,0
0.08%
-339
-304
-11.34%

-140

Net income
Million USD
Released
Forecast
Spread
-78,3
-78,8
0.74%
-80,9
-80,0
-1.1%
-65,8
-66,1
0.53%
-83,8
-83,8
0%
-339
-302
-12.01%

-169

EPS
USD
Released
Forecast
Spread
-61,3
-62,0
1.23%
-38,0
-39,0
2.56%
-25,0
-25,5
1.8%
-24,8
-25,4
2.7%
-49,1
-11,9
-314.27%

-3,68

Announcement Date24/02/2018/03/2108/03/2202/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
3,64
1,76
107.07%
1,36
0,73
87.86%
0,63
0,71
-11.91%
0,17
0,21
-16.48%
0,17
0,06
189.66%
0,20
0,08
135.71%
0,69
0,00
-
0,00
0,00
-
0,00
0,22
-

0,00


3,33


0,00


3,50




EBIT
Million USD
Released
Forecast
Spread
-20,4
-21,0
2.52%
-24,4
-23,0
-6.27%
-22,4
-23,9
6.17%
-18,8
-21,0
10.64%
-19,2
-18,3
-4.78%
-18,8
-17,8
-5.42%
-159
-14,2
-1021.45%
-32,9
-21,0
-56.89%
-45,9
-29,2
-57.46%

-39,1


-35,9


-41,6


-40,0




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-20,4
-21,0
2.55%
-24,4
-23,0
-6.3%
-22,3
-23,9
6.55%
-18,4
-20,9
11.69%
-18,8
-18,8
0.21%
-18,5
-16,6
-10.97%
-217
-14,2
-1434.09%
-40,1
-13,3
-202.67%
-63,2
-28,6
-120.91%

-36,6


-32,4


-39,3


-37,0




Net income
Million USD
Released
Forecast
Spread
-20,4
-21,0
2.44%
-24,4
-23,0
-6.3%
-22,3
-23,9
6.51%
-18,2
-20,9
12.69%
-18,8
-18,8
0.01%
-18,4
-16,6
-10.75%
-217
-14,2
-1434.14%
-40,1
-13,3
-202.69%
-63,2
-26,8
-135.91%

-42,2


-39,0


-44,9


-43,3




EPS
USD
Released
Forecast
Spread
-7,75
-7,63
-1.51%
-9,25
-8,59
-7.69%
-6,75
-7,75
12.9%
-4,75
-5,88
19.15%
-4,50
-5,06
11.11%
-5,00
-4,38
-14.29%
-56,8
-3,50
-1521.43%
-9,34
-0,85
-1005.33%
-4,05
-0,78
-416.39%

-1,17


-0,92


-0,98


-0,92


-0,40

Announcement Date08/03/2205/05/2204/08/2203/11/2202/03/2311/05/2311/08/2309/11/2329/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise